Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01035515 · ClinicalTrials.gov registry record · Phase 1
BIIB014 Cardiovascular Monitoring Study
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01035515 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 24 participants.
The verdict
NCT01035515, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study will examine the effects of a single dose of BIIB014 on blood pressure and haemodynamic variables in healthy volunteers over 24 hours.
Interventions
- DRUG Placebo
- DRUG BIIB014 50mg
- DRUG BIIB014 100mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01035515
The ClinicalTrials.gov registry entry for NCT01035515 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01035515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01035515 about?
NCT01035515 is a clinical study titled "BIIB014 Cardiovascular Monitoring Study". The study will examine the effects of a single dose of BIIB014 on blood pressure and haemodynamic variables in healthy volunteers over 24 hours.
What is the current status of trial NCT01035515?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2009-12. Estimated completion is 2010-04.
What interventions are being tested in trial NCT01035515?
The interventions under investigation include: Placebo (DRUG), BIIB014 50mg (DRUG), BIIB014 100mg (DRUG).
Who is sponsoring clinical trial NCT01035515?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.